Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 21,880 shares at $509.22 ($11.2M) on 2025-12-24, disclosed to the SEC on 2025-12-29.
Scheduled sale ($11.2M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $509.22 | 502 | $256K | 2.3% |
| 2 | $509.22 | 502 | $256K | 2.3% |
| 3 | $509.81 | 138 | $70K | 0.6% |
| 4 | $509.81 | 138 | $70K | 0.6% |
| 5 | $510.64 | 40 | $20K | 0.2% |
| 6 | $512.59 | 2,877 |
| $1.5M |
| 13.1% |
| 7 | $512.59 | 2,877 | $1.5M | 13.1% |
| 8 | $513.46 | 4,713 | $2.4M | 21.6% |
| 9 | $513.46 | 4,713 | $2.4M | 21.6% |
| 10 | $514.18 | 2,650 | $1.4M | 12.1% |
| 11 | $514.18 | 2,650 | $1.4M | 12.1% |
| 12 | $516.06 | 80 | $41K | 0.4% |
| Total | $513.17 avg | 21,880 | $11.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |